Clinical Trial Update: Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Decitabine plus BU-CY conditioning versus BU-CY alone in myeloid tumor patients undergoing allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation Conditioning
• Myeloid Tumors

Drugs mentioned

• Decitabine + BU-CY

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning | Phase 2, Phase 3 | Status: UNKNOWN